HitGen to Discover Lead Molecules for Takeda

HitGen. the Chengdu-Houston lead-generation CRO, signed a deal to discover novel drug leads for Japan 's Takeda Pharma. HitGen will search its DNA encoded chemical libraries, which HitGen says contain over 90 billion novel drug-like small molecule and macrocycle compounds, for likely candidates. The Takeda collaboration is the third that HitGen has announced in the last month. As usual, HitGen will receive an upfront payment plus milestones, though it doesn't release specifics. More details.... Share this with colleagues: // //